oxybutynin has been researched along with galantamine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| De Raedt, R; Gorus, E; Lambert, M; Mets, T | 1 |
| Ha, JM; Kim, JY; Oh, TO; Park, CW; Park, ES; Rhee, YS; Son, DD | 1 |
| Dautzenberg, PJ; Golüke, NM; Jessurun, N; Keijsers, CJ; van Strien, AM | 1 |
| Ahmad, MB; Basri, M; Ismail, M; Masoumi, HR; Woo, FY | 1 |
| Ameen, D; Michniak-Kohn, B | 1 |
| Abdelhady, SA; Hanafy, AS; Kandil, LS | 1 |
1 review(s) available for oxybutynin and galantamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for oxybutynin and galantamine
| Article | Year |
|---|---|
The influence of galantamine on reaction time, attention processes, and performance variability in elderly Alzheimer patients.
Topics: Aged, 80 and over; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Attention; Benzodiazepines; Decision Making; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Galantamine; Humans; Male; Mandelic Acids; Movement; Parasympatholytics; Patient Dropouts; Prospective Studies; Reaction Time; Selective Serotonin Reuptake Inhibitors; Task Performance and Analysis; Trazodone | 2007 |
8 other study(ies) available for oxybutynin and galantamine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system.
Topics: Adhesives; Administration, Cutaneous; Animals; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Galantamine; In Vitro Techniques; Male; Oleic Acid; Rabbits; Rats; Rats, Sprague-Dawley; Skin Absorption; Transdermal Patch | 2012 |
Skin lesions after oral acetylcholinesterase inhibitor therapy: a case report.
Topics: Administration, Oral; Aged; Cholinesterase Inhibitors; Drug Eruptions; Galantamine; Humans; Male; Phenylcarbamates; Rivastigmine; Transdermal Patch | 2014 |
Formulation optimization of galantamine hydrobromide loaded gel drug reservoirs in transdermal patch for Alzheimer's disease.
Topics: Administration, Cutaneous; Alzheimer Disease; Delayed-Action Preparations; Ethanolamines; Galantamine; Gels; Humans; Hydrogen-Ion Concentration; Models, Chemical; Polyvinyls; Reproducibility of Results; Software; Transdermal Patch | 2015 |
Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
Topics: Adhesives; Administration, Cutaneous; Aged; Alzheimer Disease; Cadaver; Crystallization; Diffusion; Drug Carriers; Drug Evaluation, Preclinical; Drug Liberation; Female; Galantamine; Humans; Limonene; Male; Medication Adherence; Nootropic Agents; Oleic Acid; Permeability; Polymers; Pressure; Skin; Skin Absorption; Spectroscopy, Fourier Transform Infrared; Transdermal Patch | 2019 |
Galantamine transdermal patch shows higher tolerability over oral galantamine in rheumatoid arthritis rat model.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Galantamine; Rats; Rats, Sprague-Dawley; Transdermal Patch | 2020 |